ADHD 300: Beyond the Basics

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program will be awarded 1.0 NAPNAP contact hours, of which 0.5 is pharmacology content/1.0 Psychopharmacology content/0.5 Controlled Substance content.

IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information. 

Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org

This presentation was supported by an education grant from Supernus.

Copyright 2020 © by National Association of Pediatric Nurse Practitioners (NAPNAP).

Keywords: ADHD, psychopharmacology, anxiety, depression

Target Audience

Pediatric-focused advanced practice registered nurses

Learning Objectives

  1. Integrate knowledge of the psychopharmacology of medications used for ADHD, anxiety and depression into their primary care patient management plans
  2. Evaluate the effectiveness of these agents in primary care patients
  3. Identify warning signs of significant medication- related side effects
  4. Incorporate patient and family teaching strategies to improve psychopharmacologic treatment

You may also be interested in

Case Study: ADHD – Part 1 - Adolescent
The team will walk the participants through an engaging case study, addressing a unique diagnosis, designed to review the diagnostic presentation and appropriate assessment tools, formulation of diagnosis with interpretation of developmental and behavioral assessment measures, treatment options including psychopharmacology, family support and ongoing monitoring of a child with multiple common developmental and behavioral concerns. 0.25Rx, 0.25PsyRx
Case Study: ADHD – Part 2 - Adolescent
The team will walk the participants through an engaging case study, addressing a unique diagnosis, designed to review the diagnostic presentation and appropriate assessment tools, formulation of diagnosis with interpretation of developmental and behavioral assessment measures, treatment options including psychopharmacology, family support and ongoing monitoring of a child with multiple common developmental and behavioral concerns.
Course summary
Available credit: 
  • 1.00 Contact hours
Course opens: 
06/15/2020
Course expires: 
12/31/2021
Cost:
$10.00
Rating: 
0

Dawn Garzon Maaks, PhD, CPNP-PC, PMHS, FAANP, University of Portland School of Nursing

Available Credit

  • 1.00 Contact hours

Price

Cost:
$10.00
Please login or register to take this course.